SMAD3 and chronic obstructive pulmonary disease: Simultaneously, it also reduced α-SMA, TGF-β1, and Smad3 levels in the lung tissue, thus indicating towards its therapeutic effect on the pulmonary injury of CS and LPS-induced COPD in rats.